Winston Kung is COO, CFO of PMV Pharmaceuticals Inc.
Person profile
Roles
Address
Summit, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Janux Therapeutics, Inc.
28 Jun 24
3
ArriVent Biopharma, Inc.
25 Jan 24
4
Janux Therapeutics, Inc.
16 Jun 23
4
PMV Pharmaceuticals, Inc.
15 May 23
4
PMV Pharmaceuticals, Inc.
30 Jan 23
4
Janux Therapeutics, Inc.
22 Sep 22
3
Janux Therapeutics, Inc.
22 Sep 22
4
PMV Pharmaceuticals, Inc.
21 Apr 22
4
PMV Pharmaceuticals, Inc.
28 Feb 22
4
PMV Pharmaceuticals, Inc.
8 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Jun 24 | JANX Janux Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,500 | 0.00 | 2,500 |
26 Jun 24 | JANX Janux Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 39.8 | 8,350 | 332.33 k | 8,350 |
14 Jun 23 | JANX Janux Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 13.22 | 12,500 | 165.25 k | 12,500 |
12 May 23 | PMVP PMV Pharmaceuticals | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.7 | 150,000 | 855.00 k | 150,000 |